Advertisement

Topics

EKF POCT HbA1c testing confirmed as comparable to lab-based HPLC

08:35 EDT 21 Jun 2017 | News-Medical.net

EKF Diagnostics, the global in vitro diagnostics company, announces that a recent study has confirmed that its Quo-Test® A1c point-of-care testing (POCT) analyzer shows comparable performance to a lab-based HPLC system for the measurement of glycated hemoglobin (HbA1c). Recently published in Practical Laboratory Medicine, the study undertaken by the Diabetes Research Unit Cymru, Swansea University, UK, also observed that under the correct circumstances using WHO guidelines Quo-Test is appropriate for the diagnosis of Type 2 diabetes.

Original Article: EKF POCT HbA1c testing confirmed as comparable to lab-based HPLC

NEXT ARTICLE

More From BioPortfolio on "EKF POCT HbA1c testing confirmed as comparable to lab-based HPLC"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...